Pfizer to buy antibiotics business from AstraZeneca
Pharmaceutical company AstraZeneca (AZN.L) has agreed to sell its small molecule antibiotics business to Pfizer Inc…
Pfizer nears deal to acquire Medivation for close to $14 billion
Pfizer Inc (PFE.N) is in advanced talks to acquire U.S. cancer drug company Medivation Inc (MDVN.O) for close to…
Pfizer approaches Medivation about potential takeover
Pfizer Inc (PFE.N) has approached U.S. cancer drug maker Medivation Inc (MDVN.O) to express interest in an…
Pfizer-Allergan deal faces new U.S. inversion rules
The U.S. Treasury Department took new steps on Monday to curb tax-avoiding corporate "inversions," with the pending…
Pfizer, Allergan say combined drug pipeline ‘underappreciated’
The research chiefs of betrothed drugmakers Pfizer Inc (PFE.N) and Allergan (AGN.N) say the proposed combination of…
Pfizer raises U.S. prices for over 100 drugs on January 1
Pfizer Inc (PFE.N), which plans a $160-billion merger with Ireland-based Allergan Plc (AGN.N) to slash its U.S. tax…
Pfizer to buy Allergan for more than $150 billion
Pfizer Inc (PFE.N) secured formal board approval on Sunday for its acquisition of Botox maker Allergan Plc (AGN.N)…
Pfizer in merger talks with Botox-maker Allergan: WSJ
Pharmaceutical giant Pfizer Inc (PFE.N) recently approached Botox-maker Allergan Plc (AGN.N) to discuss what could…
India rejects patent on Pfizer’s arthritis drug
India has again denied Pfizer Inc a patent on its rheumatoid arthritis drug tofacitinib, the latest setback for a…
Pfizer wins EU approval for $15 billion Hospira buy
U.S. drugmaker Pfizer (PFE.N) gained European Union antitrust approval on Tuesday for its proposed $15 billion…
